NEW YORK – Abbott announced on Monday that its Alinity H-Series hematology system has received 510(k) clearance from the US Food and Drug Administration.
The system includes the Alinity HQ automated hematology analyzer and the Alinity HS integrated slide maker and stainer, the company noted in a statement. The Alinity HQ uses Abbott's Multi-Angle Polarized Scatter Separation (MAPSS) technology, which utilizes "light scattering to distinguish cellular features and better identify various blood cells," it said.
The system can process up to 119 complete blood count tests per hour and can be integrated into existing core laboratory operations, Abbott noted. It also offers hands-off automated maintenance and provides customizable reports and rules for systems.
The Alinity H-Series joins Abbott's other Alinity platforms that are available in the US, including the Alinity CI for clinical chemistry and immunoassays, the Alinity M for molecular testing, the Alinity S for transfusion, and the point-of-care i-STAT Alinity.